A significant discovery in cancer investigation is arising with the use of VHH fragments to re-engage mutated p53. This essential malignant inhibitor protein is frequently inactivated in various kinds of tumors, https://active-bookmarks.com/story21838753/mini-antibodies-restore-p53-new-promising-pathway-for-malignant-management